Transitioning from Private to Public: Life Sciences IPO exit strategies

A virtual discussion presented by Deloitte’s Capital Markets Transactions practice.

Please join Deloitte Life Sciences IPO leaders Tasia Blazevich and B.J. Spence as they lead us through key considerations and strategies. Tasia and B.J. will be joined by industry leaders who will share their perspectives on navigating the IPO process.

You will hear from industry leading professionals and experienced executives addressing topics such as:

• Capital markets update
• IPO strategy overview
• Perspectives from industry leading advisors

Speakers include:

• Tasia Blazevich, US Life Sciences IPO leader, Deloitte
• B.J. Spence, US Life Sciences IPO Leader, Deloitte
• John Haynor, Managing Director, Solebury
• Carlos Ramirez, Partner, Cooley